2020 is the gift that keeps on giving. In this episode, Paul Breitbarth and K Royal revisit some of the issues discussed on previous episodes, but with a guest who has a unique global perspective. Our guest today is an American in Brussels. He is the Deputy Chief Privacy Officer of the US-based pharmaceutical company Merck. Chris Foreman has practiced law in London, Washington DC, Istanbul, New York and Moscow, and is currently based in Brussels.
Merck, or MSD as it is often known, has been an active player in the international corporate privacy community, and a big advocate for interoperability and company-wide compliance programs. They are one of the few companies that has both EU Binding Corporate Rules and APEC Cross-Border Privacy Rules, trying to ensure the best possible safeguards for international data transfers. There is even a published cross-walk between the two.
Join us as we talk with Chris about his views on international data transfers. As expected, we will discuss the Schrems-II decision and its impact on data transfers, but we touch on many other topics as well that are integral to a global privacy program. These include the California Consumer Privacy Act (CCPA) and the ballot initiative, the California Privacy Rights Act (CPRA, Proposition 24), South Korea, Brazil (LGPD), clinical trials, and other twists to privacy law that we are starting to see.
Twitter: @privacypodcast, @EuroPaulB, @heartofprivacy, @trustarc,